Back from ASH 2025, Dr Suchitra Sundaram reports on notable frontline CLL data. Time‑limited pirtobrutinib combined with venetoclax and obinutuzumab produced high rates of undetectable minimal ...

Until recently, a chronic lymphocytic leukemia (CLL) diagnosis came with limited options and a lot of uncertainty. Today, long-term results show how much treatment has changed — and what patients and ...

Linda Hoffman-Pugh, a former housekeeper for JonBenét Ramsey‘s family, has died at the age of 82. Hoffman-Pugh was working for the family when JonBenét was tragically murdered at just 6 years old on ...

Patsy Cochran Kishler passed away at The Arbors at Carroll on May 12, 2026. She was a breast cancer survivor and, during the last seven months of her life, dealt with Stage 4 kidney cancer. She was ...

Patsy Kensit will return to Emmerdale after two decades to reprise her role as Sadie King. The actress played the villainous character on the ITV soap for a two-year stint between 2004 and 2006. She ...

Emmerdale has confirmed the return of Patsy Kensit as Sadie King. It was recently reported that the star, who appeared on EastEnders a few years ago, would be back as the villainous character after 20 ...

You don’t mess with the classics. In a chaotic world that ceaselessly hurls distractions at us through the digital rectangular devices in our pockets, it’s often the slow, frill-less, anachronistic ...

Time-limited acalabrutinib plus venetoclax improves outcomes vs chemoimmunotherapy, offering the first FDA-approved all-oral fixed-duration CLL option, explains Adam Kittai, MD. The study compared ...

In "Beyond Diagnosis: CLL," Cleveland Clinic hematologist/oncologist Allison Winter, MD, and host John Mangels continue their conversation on communicating ...

“Bruin CLL-322 was an ambitious trial, building on an effective regimen, and these results outperformed our expectations,” Jacob Van Naarden, president of Lilly Oncology, said in an April 13 release. ...